Emerging orthopedic innovator OsteoNovus focuses on fully synthetic calcium phosphate bone substitutes for bone voids, fractures, and spinal disorders, presenting a lean, growth-oriented target for hospital systems and clinics seeking innovative biologic materials.

Spine and ortho focus Product portfolio includes injectable and moldable putty, granules, and structural blocks suitable for spinal and orthopedic procedures, enabling cross-selling opportunities across surgeons specializing in spine, trauma, and reconstructive surgery.

Early stage growth With a small team and revenue in the low millions, there is potential to partner on pilot programs, clinical adoption studies, and early access deals to establish proof points and scale adoption quickly.

Canada expansion Recent availability in Canada signals geographic expansion momentum; leverage regional distributors, hospital procurement channels, and localized regulatory support to accelerate multi-country adoption.

Funding leverage Current funding and modest revenue provide an opening for co-development, joint ventures, or strategic partnerships with larger device companies seeking to augment portfolios with innovative calcium phosphate solutions.